Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Chupp

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Chest|November 7, 2020
A Clinic Blueprint for Post-Coronavirus Disease 2019 RECOVERY: Learning From the Past, Looking to the FutureDenyse D Lutchmansingh, Melissa P Knauert, Danielle E Antin-Ozerkis, et al.
Medrxiv : the Preprint Server for Health Sciences|February 8, 2022
A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and TasteGeoffrey Chupp, Anne Spichler-Moffarah, Ole S Søgaard, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 7, 2020
Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases WorkshopRobert Naclerio, Fuad Baroody, Claus Bachert, et al.
Chest|November 14, 2021
Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years: The Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma StudyGeoffrey Chupp, Joel N Kline, Sumita B Khatri, et al.
Chest|June 20, 2020
Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical OutcomesChristina C Price, Frederick L Altice, Yu Shyr, et al.
The World Allergy Organization Journal|May 20, 2020
COVID-19, asthma, and biological therapies: What we need to knowMário Morais-Almeida, Rita Aguiar, Bryan Martin, et al.
Contemporary Clinical Trials|December 14, 2020
A randomized, open-label, pragmatic study to assess reliever-triggered inhaled corticosteroid in African American/Black and Hispanic/Latinx adults with asthma: Design and methods of the PREPARE trialElliot Israel, Juan Carlos Cardet, Jennifer K Carroll, et al.
The New England Journal of Medicine|February 25, 2022
Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with AsthmaElliot Israel, Juan-Carlos Cardet, Jennifer K Carroll, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Chest|November 7, 2020
A Clinic Blueprint for Post-Coronavirus Disease 2019 RECOVERY: Learning From the Past, Looking to the FutureDenyse D Lutchmansingh, Melissa P Knauert, Danielle E Antin-Ozerkis, et al.
Medrxiv : the Preprint Server for Health Sciences|February 8, 2022
A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and TasteGeoffrey Chupp, Anne Spichler-Moffarah, Ole S Søgaard, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 7, 2020
Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases WorkshopRobert Naclerio, Fuad Baroody, Claus Bachert, et al.
Chest|November 14, 2021
Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years: The Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma StudyGeoffrey Chupp, Joel N Kline, Sumita B Khatri, et al.
Chest|June 20, 2020
Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical OutcomesChristina C Price, Frederick L Altice, Yu Shyr, et al.
The World Allergy Organization Journal|May 20, 2020
COVID-19, asthma, and biological therapies: What we need to knowMário Morais-Almeida, Rita Aguiar, Bryan Martin, et al.
Contemporary Clinical Trials|December 14, 2020
A randomized, open-label, pragmatic study to assess reliever-triggered inhaled corticosteroid in African American/Black and Hispanic/Latinx adults with asthma: Design and methods of the PREPARE trialElliot Israel, Juan Carlos Cardet, Jennifer K Carroll, et al.
The New England Journal of Medicine|February 25, 2022
Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with AsthmaElliot Israel, Juan-Carlos Cardet, Jennifer K Carroll, et al.
Pageof 6